| Trial ID: | L4442 |
| Source ID: | NCT00528918
|
| Associated Drug: |
Glulisine (Apidra)
|
| Title: |
Comparison of Apidra to Regular Insulin in Hospitalized Patients
|
| Acronym: |
Apidra
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type II
|
| Interventions: |
DRUG: Glulisine (Apidra)
|
| Outcome Measures: |
Primary: Hypoglycemic events, up to 60 days |
|
| Sponsor/Collaborators: |
Sponsor: Carl T. Hayden VA Medical Center | Collaborators: Sanofi
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
300
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2007-06
|
| Completion Date: |
2011-05
|
| Results First Posted: |
|
| Last Update Posted: |
2014-07-24
|
| Locations: |
Phoenix VA Health Care System, Phoenix, Arizona, 85012, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00528918
|
